Night-time blood pressure is associated with the development of chronic kidney disease in a general population: The Ohasama Study

Journal of Hypertension

Volumn 31, Issue 12, 2013, Pages 2410-2417

  Kanno, Atsuhiro ^a,b   Kikuya, Masahiro ^b   Asayama, Kei ^b,c   Satoh, Michihiro ^b   Inoue, Ryusuke ^d   Hosaka, Miki ^b   Metoki, Hirohito ^b   Obara, Taku ^b   Hoshi, Haruhisa ^e   Totsune, Kazuhito ^b,f   Sato, Toshinobu ^a   Taguma, Yoshio ^a   Sato, Hiroshi ^b   Imai, Yutaka ^b   Ohkubo, Takayoshi ^b,g  

^a Division of Pathology   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

^e Ohasama Hospital   (Japan)

^f TOHOKU FUKUSHI UNIVERSITY   (Japan)

^g TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ambulatory blood pressure measurement; chronic kidney disease; dipping status; hypertension; nighttime blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NIGHT TIME BLOOD PRESSURE; PRIORITY JOURNAL; PROTEINURIA; SMOKING; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 84888130132     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328364dd0f     Document Type: Article

References (44)

1. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19: 243-250.
2. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
3. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364.
4. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245.
5. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
6. Verdecchia P, Reboldi G, Porcellati C, Schillaci G, Pede S, Bentivoglio M, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol 2002; 39:878-885.
7. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Office versus Ambulatory Pressure Study Investigators: Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
8. PalmasW, Pickering TG, Teresi J, Schwartz JE,Moran A,Weinstock RS, et al.Ambulatory blood pressuremonitoring and all-causemortality in elderly people with diabetes mellitus. Hypertension 2009; 53:120-127.
9. Palmas W, Moran A, Pickering T, Eimicke JP, Teresi J, Schwartz JE, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 2006; 48:301-308.
10. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011; 171:1090-1098.
11. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006; 69:1175-1180.
12. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51:55-61.
13. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007; 49:1235-1241.
14. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161.
15. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9:S16-S23.
16. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116:85-97.
17. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
18. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295.
19. Imai Y, Nagai K, Sakuma M, Sakuma H, Nakatsuka H, Satoh H, et al. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 1993; 22:900-912.
20. Imai Y, Abe K, Sekino H. Evaluation of automatic devices for blood pressure measurement. In: Koshikawa S, Nagasawa T, editors. Annual review nephrology, 1992 (in Japanese). Tokyo, Japan: Chugai-igakusha; 1991. pp. 55-61.
21. Association for the Advancement of Medical Instrumentation. American National Standard for Electronic or Automated Sphygmomanometers. Washington, DC: Association for the Advancement of Medical Instrumentation; 1987.
22. JCS Joint Working Group. Guidelines for the clinical use of 24 h ambulatory blood pressure monitoring (ABPM) (JCS 2010)-digest version. Circ J 2012; 76:508-519.
23. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population-the Ohasama study. Nephrol Dial Transplant 2007; 22:1910-1915.
24. Kikuya M, Hansen TW, Thijs L, Björklund-Bodega°rd K, Kuznetsova T, Ohkubo T, et al. International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115:2145-2152.
25. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
26. Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, et al. Multiinstitutional validation study of carboplatin dosing formula using adjusted serum creatinine level. Clin Cancer Res 2000; 6: 4733-4738.
27. Junge W, Wilke B, Halabi A, Klein G. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method. Clin Chim Acta 2004; 344:137-148.
28. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
29. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 2010; 56:32-38.
30. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 2006; 21:2439-2445.
31. Hermida RC, Calvo C, Ayala DE, López JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 2005; 46:960-968.
32. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797-805.
33. Redon J, Plancha E, Swift PA, Pons S, Muñoz J, Martinez F. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J Hypertens 2010; 28:602-607.
34. Redon J, Lurbe E. Ambulatory blood pressure and the kidney: implications for renal dysfunction. In: Epstein M, editor. Calcium antagonists in clinical medicine. Philadelphia: Hanley & Belfus; 2002. pp. 665-679.
35. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65:621-625.
36. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999; 33:29-35.
37. Vaile JC, Stallard TJ, al-Ani M, Jordan PJ, Townend JN, Littler WA. Sleep and blood pressure: spontaneous baroreflex sensitivity in dippers and nondippers. J Hypertens 1996; 14:1427-1432.
38. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1996; 30:71-76.
39. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure 'dipping' and 'nondipping' in obstructive sleep apnea syndrome patients. Sleep 1996; 19:382-387.
40. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 2006; 166:846-852.
41. Agarwal R, Kariyanna SS, Light RP. Prognostic value of circadian blood pressure variation in chronic kidney disease. Am J Nephrol 2009; 30:547-553.
42. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Am J Kidney Dis 2002; 39 (2 Suppl 1):S1-S266.
43. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71:159-166.
44. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, et al. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 2008; 23:1265-1273.